Top

Published in:

01-08-2012 | Cardiovascular Infections (DP Levine, Section Editor)

Q Fever Endocarditis: Does Serology Predict Outcome?

Author: Arístides de Alarcón

Published in: Current Infectious Disease Reports | Issue 4/2012

Abstract

Q fever is an ubiquitous zoonosis caused by Coxiella burneti, an intracellular bacterium that can produce acute or chronic infections in humans. These forms are characterized by different evolution, serological profile and treatment that must be very long to achieve a cure in chronic forms. However, the serological profile for diagnosis and the real value of serology for predicting outcome are controversial, and management dilemmas for many patients with Q fever infection are continuously emerging. In this article, we describe in a comprehensive manner the different clinical presentations of the disease, making a critical overview of the evidence for serological predictions. We also take a broad view of new available diagnostic techniques and finally, we give recommendations for treatment.

Derrick EH. “Q” fever, a new fever entity: clinical features, diagnosis and laboratory investigations. Med J Aust. 1937;2:821–99.

Burnet FM, Freeman M. Experimental studies on the virus of “Q” fever. Med J Aust. 1937;2:299–305.

Davis GE, Cox HR. A filter-passing infectious agent isolated from ticks.I. Isolation from Dermacentor andersonii, reactions with animals, and filtration experiments. Publ Health Rep. 1938;53:2259–76.CrossRef

Dyer RE. Similarity of Australian “Q” fever and a disease caused by an infectious agent isolated from ticks in Montana. Publ Health Rep. 1939;54:1229–37.CrossRef

Dijkstra F, Hoek W, Wijers N, et al. The 2007–2010 Q fever epidemic in the Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming. FEMS Immunol Med Microbiol 2011, in press

Raoult D, Marrie T, Mege J. Natural history and pathophysiology of Q fever. Lancet Infect Dis. 2005;5:219–26.PubMedCrossRef

McCaul TF, Williams JC. Development cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol. 1981;147:1063–76.PubMed

McCaul TF. The developmental cycle of Coxiella burnetii. In: Williams JC, Thompson HA, editors. Q fever: the biology of Coxiella burnetii. Boca Raton: CRC; 1991. p. 224–58.

Baca OG, Paretsky D. Q fever and Coxiella burnetii: a model for host-parasite interactions. Microbiol Rev. 1983;47:127–49.PubMed

10.

Gonder JC, Kishimoto RA, Kastello MD, et al. Cynomolgus monkey model for experimental Q fever infection. J Infect Dis. 1979;139:191–6.PubMedCrossRef

11.

• Angelakis E, Raoult D. Q fever. Vet Microbiol. 2010;140:297–309. These authors provide a good review of many aspects of this entity and its consequences in humans and animals.PubMedCrossRef

12.

Johnson III JE, Kadu PJ. Laboratory acquired Q fever. A report of fifty cases. Am J Med. 1966;41:391–403.PubMedCrossRef

13.

Raoult D, Brouqui P, Marchou B, Gastaut JA. Acute and chronic Q fever in patients with cancer. Clin Infect Dis. 1992;14:127–30.PubMedCrossRef

14.

Raoult D, Levy PY, Dupont HT, et al. Q fever and HIV infection. AIDS. 1993;7:81–6.PubMedCrossRef

15.

Boschini A, Di Perri G, Legnani D, et al. Consecutive epidemics of Q fever in a residential facility for drug abusers: impact on persons with human immunodeficiency virus infection. Clin Infect Dis. 1999;28:866–72.PubMedCrossRef

16.

Montes M, Cilla G, Marimon JM, et al. Coxiella burnetii infection in subjects with HIV infection and HIV infection in patients with Q fever. Scand J Infect Dis. 1995;27:344–6.PubMedCrossRef

17.

Sidwell RW, Thorpe BD, Gebhardt LP. Studies of latent Q fever infections. I. Efects of whole boy X-irradiation on latently infected guinea pigs, white mice and deer mice. Am J Hyg. 1964;79:113–24.PubMed

18.

Sidwell RW, Thorpe BD, Gebhardt LP. Studies of latent Q fever infections. II. Efects of multiple cortisone injection. Am J Hyg. 1964;79:320–7.PubMed

19.

Samuel JE, Frazier ME, Mallavia LP. Correlation of plasmid type and disease caused by Coxiella burnetii. Infect Immun. 1985;49:775–9.PubMed

20.

Stein A, Raoult D. Lack of pathotype specific gene in human Coxiella burnetii isolates. Microb Pathog. 1993;15:177–85.PubMedCrossRef

21.

de Alarcón A, Villanueva JL, Viciana P, et al. Q fever: epidemiology, clinical features and prognosis. A study from 1983 to 1999 in the South of Spain. J Infect. 2003;47:110–6.PubMedCrossRef

22.

Raoult D, Tissot-Dupont H, Foucault C, et al. Q fever 1985–1998. Clinical an epidemiologic features of 1,383 infections. Medicine. 2000;79:109–23.PubMedCrossRef

23.

Spelman DW. Q fever: a stuy of 111 consecutive cases. Med J Austral. 1982;1:547–53.PubMed

24.

Pebody RG, Wall PG, Ryan ML, Fairley C. Epidemiological features of Coxiella burnetii infection in England and Wales: 1984 to 1994. Commun Dis Rep. 1996;6:128–32.

25.

Marrie TJ. Coxiella burnetii (Q fever) pneumonia. Clin Infect Dis. 1995;21 suppl 3:S253–64.PubMedCrossRef

26.

Tselentis Y, Gikas A, Kofteridis D, et al. Q fever in the Greek Island of Crete: epidemiologic, clinical, and therapeutic data from 98 cases. Clin Infect Dis. 1995;20:1311–6.PubMedCrossRef

27.

Ergas D, Keysari A, Edelstein V, Sthoeger ZM. Acute Q fever in Israel: Clinical and laboratory study of 100 hospitalized patients. Isr Med Assoc J. 2008;8(5):337–41.

28.

Clark WH, Lennete EH, Railsback OC, Romer MS. Q fever in California. Arch Intern Med. 1951;58:155–61.CrossRef

29.

Vellend H, Salit IE, Spence L. Q fever-Ontario. Can Dis Wkly Rep. 1982;8:171.

30.

Marrie TJ. Q fever, 1979–1987-Nova Scotia. Can Dis Wkly Rep. 1988;14:69–70.PubMed

31.

Montejo-Baranda M, Corral-Carranceja J, Aguirre-Errasti C. Q fever in the Basque country: 1981–1984. Rev Infect Dis. 1985;7:700–1.PubMedCrossRef

32.

Sobradillo V, Ansola P, Baranda F, Corral C. Q fever pneumonia: a review of 164 community acquired cases in the Basque country. Eur Respir J. 1989;2:263–6.PubMed

33.

Javier Alvarez Gutiérrez F, del Castillo Otero D, García Fernández A, et al. Prospective study of 221 community acquired pneumonias followed up in an outpatient clinic. Etiology and clinical-radiological progression. Med Clin (Barc). 2001;116(5):161–6.

34.

Fournier PE, Etienne J, Harle JR, et al. Myocarditis, a rare but severe manifestation of Q fever: report of 8 cases and review of the literature. Clin Infect Dis. 2001;32:1440–7.PubMedCrossRef

35.

Bernit E, Puget J, Janbon F, et al. Neurological involvement in acute Q fever. A report of 29 cases and review of the literature. Arch Intern Med. 2002;162:693–700.PubMedCrossRef

36.

• Fournier PE, Thuny F, Richet H, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51(2):131–40. The authors describe a diagnostic strategy that lead to a high percentage of aetiologic identification in blood culture-negative endocarditis. Coxiella burnetii was in this study one of the main causes.PubMedCrossRef

37.

Turk WP, Howitt G, Turnberg LA, et al. Chronic Q fever. Q J Med. 1976;45:193–217.

38.

Brouqui P, Dupont HT, Drancourt M, et al. Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis. Arch Intern Med. 1993;153:642–8.PubMedCrossRef

39.

Haldane EV, Marrie TJ, Faulkner RS, et al. Endocarditis due to Q fever in Nova Scottia: experience with five patients in 1981–1982. J Infect Dis. 1983;148:978–85.PubMedCrossRef

40.

Wilson HG, Neilson GH, Galea EG, et al. Q fever endocarditis in Queensland. Circulation. 1976;53:680–4.PubMedCrossRef

41.

Karakousis PC, Trucksis M, Dumler S. Chronic Q fever in the United States. J Clin Microbiol. 2006;44:2283–7.PubMedCrossRef

42.

Tobin MJ, Cahill N, Gearty G, et al. Q fever endocarditis. Am J Med. 1982;72:396–400.PubMedCrossRef

43.

Siegman-Igra Y, Kaufman O, Keysary A, et al. Q fever endocarditis in Israel and a worldwide review. Scand J Infect Dis. 1997;29:41–9.PubMedCrossRef

44.

•• Mogollón MV, Anguita MP, Aguado JM, et al. Q fever endocarditis in Spain. Clinical characteristics and outcome. Enferm Infecc Microbiol Clin. 2011;29(2):109–16. This article reports a large cohort of patient with endocarditis. The utility of serology for predicting the outcome is largely questioned.PubMedCrossRef

45.

Perez-Fontan M, Huarte E, Tellez A, et al. Glomerular nephropathy associated with chronic Q fever. Am J Kidney Dis. 1988;11(4):298–306.PubMed

46.

Leipidi H, Houpikian P, Liang Z, Raoult D. Cardiac valves in patients with Q fever endocarditis:microbiological, molecular and histologic studies. J Infect Dis. 2003;187:1097–106.CrossRef

47.

•• Million M, Thuny F, Richet H, Raoult D. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis. 2010;10(8):527–35. The authors from the French National Reference Center for Rickettsial Diseases describe their experience with the largest serie of the world. Considerations about the optimun duration of treatment are provided with special consideration to serology.PubMedCrossRef

48.

Botelho-Nevers E, Fournier PE, Richet H, et al. Coxiella burnetii infection of aortic aneurysms or vascular grafts: report 30new cases and evaluation of outcome. Eur Clin Microbiol Infect Dis. 2007;26(9):635–40.CrossRef

49.

Wegdam-Blans MCA, Vainas T, van Sambeek MR, et al. Vascular complications of Q-fever infections. Eur J Vasc Endovasc Surg. 2011;42:384–92.PubMedCrossRef

50.

Nourse C, Allworth A, Jones A, et al. Three cases of Q fever osteomyelitis in children and a review of the literature. Clin Infect Dis. 2004;39:e61–6.PubMedCrossRef

51.

Landais C, Fenollar F, Constantin A, et al. Q fever osteoarticular infection: four new cases and a review of the literature. Eur J Clin Microbiol Infect. 2007;26:341–7.CrossRef

52.

Delsol G, Pellegrini M, Familiades J, Auvergnat C. Bone marrow lesions in Q fever. Blood. 1978;52:637–8.PubMed

53.

Zoutman DE, Ralph ED, Frei JV. Hepatic fibrin-ring granulomas in granulomatous hepatitis: report of four cases and review of the literature. Acta Clin Belg. 2001;56(6):341–8.

54.

Stein A, Raoult D. Q fever during pregnancy: a public health problem in southern France. Clin Infect Dis. 1998;27(3):592–6.PubMedCrossRef

55.

• Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A. Q fever during pregnancy:a cause of poor fetal and maternal outcome. Ann N Y Acad Sci. 2009;116:79–8956. In this article the authors recommend to treat pregnant women with Q fever to avoid obstetric complications and maternal chronic Q fever.CrossRef

56.

Rey D, Obadia Y, Tissot-Dupont H, Raoult D. Seroprevalence of antibodies to Coxiella burnetii among pregnant women in South Eastern France. Eur J Obstet Gynecol Reproduc Biol. 2009;93(2):57–61.

57.

Baud D, Peter O, Langel C, Regan L, Greub G. Seroprevalence of Coxiella burnetii and Brucella abortus among pregnant women. Clin Microbiol Infect. 2009;15(5):499–501.PubMedCrossRef

58.

• van der Hoek W, Meekelenkamp JC, Leenders AC, et al. Antibodies against Coxiella burnetii and pregnancy outcome during the 2007–2008 Q fever outbreaks in The Netherlands. BMC Infect Dis. 2011;11:44. In this article, the authors conclude that there is no evidence of adverse pregnancy outcome among women who had antibodies to C. burnetii during early pregnancy.PubMedCrossRef

59.

Munster JM, Leenders AC, van der Hoek W, et al. Cost-effectiveness of a screening strategy for Q fever among pregnant women in risk areas: a clustered randomized controlled trial. BMC Womens Health. 2010;10:32.PubMedCrossRef

60.

Houpikian P, Raoult D. Diagnostic methods, current best practices and guidelines for identification of difficult-to-culture pathogens in infective endocarditis. Infect Dis Clin North Am. 2002;16(2):377–92.PubMedCrossRef

61.

•• Omsland A, Heinzen RA. Life on the outside: the rescue of Coxiella burnetii from its host cell. Annu Rev Microbiol. 2011;65:111–28. Excellent article in wich the long way to the isolation of Coxiella burnetii in an axenic medium is thoughtfully described.PubMedCrossRef

62.

Peacock MG, Phillip RN, Williams JC, Faulkner R. Serological evaluation of Q fever in humans: enhanced phase I titers of Immunoglobulins G and A are diagnostic for Q fever endocarditis. Infect Immun. 1983;41:1089–98.PubMed

63.

Musso D, Raoult D. Serological cross-reactions between Coxiella burnetii and Legionella micdadei. Clin Diagn Lab Immunol. 1997;4(2):208–12.PubMed

64.

Schramek S, Kazár J, Sádecký E. Serological cross-reactions of lipid A components of lipopolysaccharides isolated from Chlamydia psittaci and Coxiella burnetii. Acta Virol. 1980;24(3):224.PubMed

65.

La Scola B, Raoult D. Serological cross-reactions between Bartonella quintana, Bartonella henselae, and Coxiella burnetii. J Clin Microbiol. 1996;34(9):2270–4.PubMed

66.

Raoult D, Tissot-Dupont H, Foucault C, et al. Q fever 1985–1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore). 2000;79(2):109–23.CrossRef

67.

Fournier PE, Casalta JP, Habib G, et al. Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. Am J Med. 1996 Jun;100(6):629–33.

68.

• van der Hoek W, Versteeg B, Meekelenkamp JC, Renders NH, Leenders AC, Weers-Pothoff I, Hermans MH, Zaaijer HL, Wever PC, Schneeberger PM. Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clin Infect Dis. 2011;52(12):1431–6. In this study, a considerable number of patients with acute Q fever exhibited high antibodies titers to phase I antigens, but no evolution to chronic form was observed.PubMedCrossRef

69.

• Hung MN, Lin LJ, Hou MY, et al. Serologic assessment of the risk of developing chronic Q fever in cohorts of acutely infected individuals. J Infect. 2011;62(1):39–44. High titers of phase I IgG and even progressive elevation of them ater an acute Q fever infection do not indicate or predict the development of chronic Q fever in this report.PubMedCrossRef

70.

Frankel D, Richet H, Renvoisé A, Raoult D. Q fever in France, 1985–2009. Emerg Infect Dis. 2011;17(3):350–6.PubMed

71.

Fenollar F, Fournier PE, Carrieri MP, et al. Risk factors and prevention of Q fever endocarditis. Clin Infect Dis. 2001;33:312–6.PubMedCrossRef

72.

Fenollar F, Thuny F, Xeridat B, et al. Endocarditis after acute Q fever in patients with previously undiagnosed valvulopathies. Clin Infect Dis. 2006;42(6):818–21.PubMedCrossRef

73.

•• Healy B, van Woerden H, Raoult D, et al. Chronic Q fever: different serological results in three countries--results of a follow-up study 6 years after a point source outbreak. Clin Infect Dis. 2011;52(8):1013–9. In this study, concordance in immnunofluorescence result interpretation from 3 international reference laboratories was only 35 %. The interpretation o chronic serological profiles must be done with caution and always in accordance with the clinical picture.PubMedCrossRef

74.

Meekelenkamp JC, Schneeberger PM, Wever PC, Leenders AC. Comparison of ELISA and indirect immunofluorescent antibody assay detecting Coxiella burnetii IgM phase II for the diagnosis of acute Q fever. Eur J Clin Microbiol Infect Dis. 2011 Oct 14 (in press)

75.

• Jager MM, Weers-Pothoff G, Hermans MH, et al. Evaluation of a diagnostic algorithm for acute Q fever in an outbreak setting. Clin Vaccine Immunol. 2011;18(6):963–8. In this article the authors reported their experience with serology (ELISA), immunofluorescece and PCR for acute Q fever diagnosis during the large outbreak in the Netherlands.A simple and effective algorithmis proposed.PubMedCrossRef

76.

Limonard GJ, Thijsen SF, Bossink AW, et al. Developing a new clinical tool for diagnosing chronic Q fever: the Coxiella ELISPOT. FEMS Immunol Med Microbiol. 2012;64(1):57–60.PubMedCrossRef

77.

Schneeberger PM, Hermans MH, van Hannen EJ, et al. Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clin Vaccine Immunol. 2010;17(2):286–90.PubMedCrossRef

78.

•• Fenollar F, Fournier PE, Raoult D. Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection. J Clin Microbiol. 2004;42(11)):4919–24. In this study, the efficacy of PCR in blood samples for the diagnosis of chronic forms (mainly endocarditis) is analysed.PubMedCrossRef

79.

• Landais C, Fenollar F, Thuny F, Raoult D. From acute Q fever to endocarditis: serological follow-up strategy. Clin Infect Dis. 2007;44(10):1337–40. French authors propose in this study an algorithm based in serology and genomic amplification for preventing the development of chronic forms.PubMedCrossRef

80.

Raoult D. Treatment of Q fever. Antimicrob Agents Chemother. 1993;37:1733–6.PubMedCrossRef

81.

Yeaman MR, Mitscher LA, Baca OG. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob Agents Chemother. 1987;31(7):1079–84.PubMedCrossRef

82.

Ormsbee RA, Parker RA, Picens EG. The comparative effectiveness of aureomycin, terramycin, chloramphenicol erythromycin, and thiocymetin in suppressing experimental rickettsial infections in chick embryos. J Infect Dis. 1955;96(2):162–7.PubMedCrossRef

83.

Raoult D, Marrie T. Q fever. Clin Infect Dis. 1995;20:489–96.PubMedCrossRef

84.

Lai CH, Lin JN, Chang LL, Chen YH, Lin HH. Circulating cytokines and procalcitonin in acute Q fever granulomatous hepatitis with poor response to antibiotic and short-course steroid therapy: a case report. BMC Infect Dis. 2010;10:193.PubMedCrossRef

85.

Crespo M, Sopeña B, Bordón J, et al. Steroids treatment of granulomatous hepatitis complicating Coxiella burnetii acute infection. Infection. 1999;27(2):132–3.PubMedCrossRef

86.

Garcia-Alfranca F, Clemente-Rodriguez C, Pigrau-Serrallach C, et al. Q fever associated with persistent fever: an immunologic disorder? Clin Infect Dis. 1994;18(1):122–3.PubMedCrossRef

87.

Stein A, Raoult D. Q fever endocarditis. Eur Heart J. 1995;16:19–23.PubMed

88.

Levy PY, Drancourt M, Etienne J. Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis. Antimicrob Agents Chemother. 1991;35(3):533–7.PubMedCrossRef

89.

Maurin M, Benoliel AM, Bongrand P, Raoult D. Phagolysosomes of Coxiella burnetii-infected cells lines maintains an acidic pH during persistant infection. Infect Immun. 1992;60:5013–6.PubMed

90.

Maurin M, Benoliel AM, Bongrand P, Raoult D. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. J Infect Dis. 1992;33:428–31.

91.

Raoult D, Houpikian P, Tissot-Dupont H, Riss JM, Arditi-Djiane J, Brouqui P. Treatment of Q fever endocarditis. Comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med. 1999;159:167–73.PubMedCrossRef

92.

Abril V, Ortega E, Segarra P, Fraile T. Late recurrence of endocarditis caused by Coxiella burnetii folowing prosthetic valve substitution and prolonged antibiotic treatment. Enferm Infecc Microbiol Clin. 1999;17:478–9.

93.

Morguet AJ, Jansen A, Raoult D, Schneider T. Late relapse of Q fever endocarditis. Clin Res Cardiol. 2007;96:519–21.PubMedCrossRef

94.

Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30(19):2369–413.PubMedCrossRef

95.

Rolain JM, Mallet MN, Raoult D. Correlation between serum doxycycline concentrations and serologic evolution in patients with Coxiella burnetii endocarditis. J Infect Dis. 2003;188:1322–5.PubMedCrossRef

96.

Lecaillet A, Mallet MN, Raoult D, Rolain JM. Therapeutic impact of the correlation of doxycycline serum concentrations and the decline of phase I antibodies in Q fever endocarditis. J Antimicrob Chemother. 2009;63(4):771–4.PubMedCrossRef

97.

Sánchez-Recalde A, Maté I, López E, et al. Coxiella burnetii endocarditis: long term follow up of 20 patients. Rev Esp Cardiol. 2000;53:940–6.PubMedCrossRef

98.

Houpikian P, Habib G, Mesana T, Raoult D. Changing clinical presentation of Q fever endocarditis. Clin Infect Dis. 2002;34:e28–31.PubMedCrossRef

Title: Q Fever Endocarditis: Does Serology Predict Outcome?
Author: Arístides de Alarcón
Publication date: 01-08-2012
Publisher: Current Science Inc.
Published in: Current Infectious Disease Reports / Issue 4/2012
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI: https://doi.org/10.1007/s11908-012-0264-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2012

Rhino-Orbital-Cerebral Mucormycosis

Enterococcal Endocarditis: Can We Win the War?

Ventricular Assist Device Infections

Balamuthia Mandrillaris Amoebic Encephalitis: An Emerging Parasitic Infection

Vaccination Against Rheumatic Heart Disease: A Review of Current Research Strategies and Challenges

CMV Retinopathy in the Antiretroviral Therapy Era: Prevention, Diagnosis, and Management

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials